/ Overview
Our Market Research Approach in Asia
Our healthcare market research approach across Asia combines secondary research, primary fieldwork, demand assessment, market sizing, and commercial analysis to support strategic and investment decisions. Through a five-step methodology, we investigate healthcare needs, market dynamics, stakeholder requirements, and competitive conditions before developing practical recommendations.
Healthcare opportunities depend on more than population growth or disease prevalence. Patient access, reimbursement policies, clinical practices, hospital procurement, provider capacity, and distribution arrangements can influence whether demand translates into a viable market. We examine these factors within individual countries and across selected Asian markets to help organisations distinguish underlying healthcare needs from commercially addressable opportunities.
/ Our Method
Our Market Research Methodology in 5 Steps
Our methodology follows five interconnected stages, with the research scope, analytical tools, and stakeholder engagement tailored to each healthcare sector, target country, and business decision.
-
Define the business decision
We establish the decisions the research must support, whether healthcare market entry, hospital expansion, product commercialisation, service development, or investment evaluation. Objectives are translated into research questions, target populations, and assessment criteria.
Output: Research scope, objectives, and research plan.
-
Desk research
We examine healthcare statistics, epidemiological information, regulatory frameworks, reimbursement policies, provider data, and industry publications. The initial analysis establishes market context and identifies assumptions that require further testing.
Output: Preliminary market assessment and research gaps.
-
Primary research & fieldwork
We gather perspectives from healthcare executives, clinicians, procurement teams, payers, distributors, patients, and other relevant stakeholders. Interviews, surveys, and facility assessments are selected to investigate real market needs and adoption conditions.
Output: Primary research findings and market insights.
-
Market sizing & triangulation
Where relevant, we estimate market potential using patient populations, treatment volumes, service utilisation, provider capacity, and pricing or reimbursement data. Top-down and bottom-up calculations are compared against clinical and commercial evidence.
Output: Market sizing model, validated assumptions, and supporting analysis.
-
Recommendations & decision support
We evaluate strategic alternatives against market attractiveness, patient needs, regulatory conditions, financial feasibility, and execution requirements. Recommendations define commercial priorities, investment considerations, and practical next steps.
Output: Research report, strategic recommendations, and decision-support materials.
/ Data Sources
Which Data Sources Do We Use in Asia?
Healthcare market research across Asia requires evidence from national health authorities, statistical agencies, healthcare regulators, industry publications, and direct stakeholder engagement. We assess source reliability, reporting periods, and differences in healthcare-system definitions before comparing markets or developing commercial estimates.
| Source type | Examples | Research application |
|---|---|---|
| Official statistics | National health ministry publications, WHO Global Health Observatory, Singapore Department of Statistics, Statistics Indonesia (BPS), national statistics agencies | Population, disease burden, healthcare expenditure, and service utilisation |
| Ministries & regulators | Singapore Ministry of Health (MOH), Indonesia Ministry of Health, Malaysia Ministry of Health, Thailand Ministry of Public Health, relevant national medical-product regulators | Healthcare regulations, licensing, reimbursement, and sector developments |
| Chambers & industry bodies | Healthcare industry associations, pharmaceutical and medical-device associations, hospital associations, and professional healthcare organisations | Healthcare stakeholder networks, market participants, and potential partners |
| Industry & company data | Hospital reports, healthcare company disclosures, medical technology publications, insurance information, and commercial databases | Provider benchmarking, market performance, service capacity, and competitive analysis |
| Primary research | Clinician interviews, hospital procurement research, patient surveys, distributor consultations, and facility assessments | Patient needs, purchasing behaviour, pricing, and validation of secondary findings |
/ Fieldwork
How We Run Primary Research and Fieldwork in Asia
Primary healthcare research requires access to stakeholders with different clinical, financial, regulatory, and purchasing responsibilities. We adapt interviews, surveys, and fieldwork methods to the healthcare environment, taking account of patient confidentiality, institutional procedures, and differences between national healthcare systems.
Depending on the engagement, research may cover Singapore, Malaysia, Thailand, Indonesia, Vietnam, the Philippines, and other relevant Asian markets. Participants may include hospital administrators, clinicians, laboratory managers, pharmaceutical buyers, procurement teams, payers, distributors, healthcare investors, and patients where appropriate.
Methods
In-depth stakeholder interviews, patient and provider surveys, facility assessments, clinical pathway mapping, hospital procurement research, and market observations.
Languages
Interviews and surveys may be conducted in English and relevant local languages, with translation or language support arranged according to respondent and country requirements.
Scheduling
Research planning considers clinical schedules, institutional approvals, patient availability, national holidays, and coordination across different healthcare markets.
Respondent recruitment
Participants are identified through healthcare stakeholder mapping, professional networks, institutional coordination, and project-specific screening criteria.
/ Market Sizing
How We Size and Validate a Market in Asia
We estimate healthcare market size by examining eligible patient populations, treatment demand, provider capacity, service utilisation, and market pricing. Top-down and bottom-up estimates are compared to assess the gap between healthcare needs and commercially addressable demand, with assumptions validated against country-specific evidence.
Top-down
Start with population data, epidemiological indicators, healthcare expenditure, and service utilisation, then refine the estimate by country, eligible patient group, treatment category, and access conditions.
Triangulation
Compare both calculations, investigate differences through provider interviews and capacity assessments, and test patient access, utilisation, and pricing assumptions to establish a defensible market size range.
Bottom-up
Estimate annual market value using eligible treatment volumes, average service frequency, and realised revenue per treatment, supported by healthcare provider data and primary research.
Market Sizing: Private Fertility Treatment Services in Asia
Business question
What is the estimated annual market value of private IVF treatment services across Thailand, Malaysia, and Singapore?
Top-down estimate
US$620m
Eligible treatment demand and private fertility expenditure assumptions
Bottom-up estimate
US$550m
Annual IVF treatment cycles × average realised revenue per cycle
Triangulation
Both estimates are reviewed against fertility clinic capacity, treatment uptake, patient affordability, cross-border patient flows, and pricing differences to reconcile country-level demand assumptions.
Estimated market range
US$550–620m
Decision implication: Identify priority fertility markets, assess clinic capacity requirements, and evaluate opportunities for service expansion and strategic partnerships.
/ By Decision
How the Method Changes by Business Decision
Healthcare organisations face different decisions involving population needs, market access, clinical capacity, growth, and investment. We select the relevant combination of market research, stakeholder analysis, commercial modelling, and feasibility assessment to address each objective.
| Your decision | Method mix | Deliverable | Service page |
|---|---|---|---|
| How should we set healthcare priorities? | Population needs analysis + system assessment + stakeholder research | Healthcare strategy roadmap | Healthcare Strategy & Market Intelligence → |
| Where are healthcare needs unmet? | Disease burden analysis + service utilisation + capacity mapping | Healthcare needs assessment | Healthcare Demand & Needs Assessment → |
| How can we strengthen healthcare system performance? | Peer benchmarking + capability assessment + service delivery review | Healthcare improvement roadmap | Healthcare Benchmarking & System Development → |
| Which healthcare market should we enter? | Market sizing + regulatory and reimbursement assessment + customer segmentation | Market entry and growth roadmap | Market Entry & Growth Strategy → |
| How do we understand demand and competition? | Market research + provider interviews + competitive intelligence | Healthcare market assessment | Market Research & Competitive Intelligence → |
| Which distributor or commercial partner? | Partner mapping + channel research + hospital procurement interviews | Partner shortlist and go-to-market plan | Go-to-Market, Partner & Distribution Strategy → |
| Is a new hospital investment viable? | Patient catchment analysis + service demand modelling + CAPEX/OPEX assessment | Hospital feasibility report | Hospital Market & Feasibility Studies → |
| How should we expand hospital services? | Patient flow analysis + service-line benchmarking + capacity planning | Hospital expansion strategy | Hospital Growth & Expansion Strategy → |
| Is this healthcare acquisition worth pursuing? | Commercial due diligence + market assessment + provider performance review | Healthcare investment assessment | Healthcare Investment & Commercial Due Diligence → |
/ By Sector
How the Method Changes by Sector
Healthcare market research requirements vary across clinical services, medical products, technologies, and investment activities. Our methods reflect the different regulatory, reimbursement, procurement, and patient-demand factors influencing each healthcare sector.
Pharmaceutical
Patient population analysis, treatment pathway research, prescribing behaviour assessment, reimbursement reviews, and pharmaceutical market access analysis.
View sector →Medical Devices
Hospital procurement research, device adoption analysis, clinical stakeholder interviews, competitor benchmarking, and distributor capability assessments.
View sector →Healthcare Providers
Patient catchment analysis, service capacity benchmarking, healthcare utilisation forecasting, and provider growth assessments.
View sector →Diagnostics
Testing demand estimation, laboratory segmentation, diagnostic workflow assessment, and technology and procurement benchmarking.
View sector →Digital Health
Digital adoption research, clinical workflow mapping, platform evaluation, reimbursement analysis, and healthcare technology commercialisation assessment.
View sector →Healthcare Investment
Healthcare market attractiveness analysis, commercial due diligence, provider performance benchmarking, and investment feasibility modelling.
View sector →/ Timelines
How Long Does Market Research in Asia Take?
Healthcare market research projects across Asia generally require 6–12 weeks for defined assessments, depending on the countries involved, availability of healthcare data, stakeholder accessibility, and research complexity. Projects involving institutional approvals, detailed clinical assessments, hospital feasibility, or multi-country fieldwork may take longer.
Research schedules account for scoping, data collection, stakeholder engagement, validation, analysis, and reporting. Team composition is adapted to the assignment, drawing on healthcare researchers, sector specialists, financial analysts, and fieldwork support where required.
| Project type | Typical duration | Typical team |
|---|---|---|
| Desk-led market assessment | 4–6 weeks | Project manager + healthcare research analysts |
| Interview-based market study | 6–10 weeks | Project manager + analysts + healthcare sector specialists |
| Large-scale survey / fieldwork | 10–16 weeks | Research team + country fieldwork coordinators |
| Feasibility study | 10–16 weeks | Project manager + healthcare and financial specialists |
/ Method in Practice
How Our Research Methods Work in Practice
Healthcare Investment
Evaluating a Specialty Clinic Acquisition in the Philippines
Issue
A healthcare investor considering the acquisition of a specialty clinic network in the Philippines needed an independent assessment of its commercial potential. Although the target reported strong growth, uncertainties remained around patient volumes, physician concentration, referral relationships, payer exposure, and the viability of planned expansion across Metro Manila and regional cities.
Approach
The commercial due diligence combined clinic catchment analysis, patient demand assessment, competitor benchmarking, and financial forecast validation. Interviews with patients, physicians, referral partners, and healthcare stakeholders provided additional evidence on service reputation, referral dependence, and unmet demand.
Recommendation
We recommended adjusting the transaction valuation to account for physician and referral concentration, prioritising expansion in two regional cities, and deferring a lower-potential clinic investment. The proposed post-acquisition plan also included specialist retention measures, selected service-line development, and stronger performance monitoring.
Engagement ROI
The assessment supported a 10% revision to the proposed transaction value and prevented investment in a lower-potential location. It also identified three adjacent service opportunities with the potential to increase network revenue by an estimated 12% over three years, strengthening the investor’s acquisition and expansion decisions.
Digital Health
Commercialising a Chronic-Care Digital Health Platform in Singapore
Issue
A digital health company preparing to commercialise a remote chronic-care platform in Singapore needed to validate provider adoption, clinical workflows, regulatory considerations, and institutional willingness to pay. Early market interest existed, but the company lacked sufficient evidence to determine which commercial model and customer segments offered the strongest launch potential.
Approach
The assessment combined patient and clinician interviews, clinical workflow mapping, regulatory reviews, and business-model evaluation. We examined interoperability requirements, adoption barriers, pricing structures, and potential partnerships with healthcare providers, insurers, and employers.
Recommendation
We recommended a provider-led commercialisation strategy, initially focusing on two chronic-care use cases. The roadmap prioritised integration with existing clinical workflows, controlled institutional pilots, stronger clinical governance, and partnerships capable of supporting wider adoption.
Engagement ROI
The revised pilot increased patient enrolment by 32% compared with the earlier test programme. Streamlined workflows reduced care-team onboarding time by 27%, while active-patient retention improved by 17% over six months. The engagement also developed a qualified pipeline of nine healthcare providers and insurers.
Medical Devices
Strengthening Medical Device Distribution in Malaysia
Issue
A multinational medical-device company operating through several Malaysian distributors needed to improve commercial visibility and partner performance. Inconsistent hospital coverage, limited tender information, uneven after-sales support, and inventory challenges made it difficult to manage strategic accounts and maintain effective market access.
Approach
The study combined distributor performance assessments, hospital procurement research, regulatory reviews, and stakeholder interviews. We evaluated account coverage, technical service capabilities, inventory management, tender participation, and alternative direct and distributor-led commercial models.
Recommendation
We recommended retaining the strongest distributor, replacing an underperforming partner, and managing selected strategic hospital accounts more directly. The proposed channel model introduced clearer responsibilities, performance indicators, inventory planning, and regular business reviews.
Engagement ROI
The revised distribution strategy increased qualified hospital coverage by 21% during the first year and improved forecast accuracy by 24%. Better inventory management reduced slow-moving stock by 15%, while improved tender visibility supported more focused commercial resource allocation.
Want to know who we are? About Asian Healthcare Market Research →
Frequently Asked Questions
-
We combine top-down and bottom-up estimates using patient population data, disease prevalence, service utilisation, provider capacity, and healthcare expenditure. Calculations are tested against clinical and commercial evidence to establish a defensible market size range for the relevant countries and service categories.
-
We use national healthcare statistics, health ministry publications, regulatory information, WHO datasets, healthcare provider reports, industry databases, and primary research. Sources are selected according to the healthcare sector, target markets, and research objectives, with attention to data reliability and comparability.
-
We assess healthcare competitors through provider mapping, service and product comparisons, pricing reviews, procurement research, and stakeholder interviews. Depending on the sector, benchmarking may cover clinical capabilities, patient access, medical technology, distribution networks, and commercial performance.
-
We interview hospital executives, clinicians, procurement teams, laboratory managers, distributors, and other decision-makers to understand purchasing requirements, clinical priorities, supplier selection, and budget considerations. The findings support customer segmentation, account prioritisation, and healthcare go-to-market strategies.
-
Healthcare interviews may be conducted in English or relevant local languages, according to country and respondent requirements. Additional arrangements can be made for clinical terminology, translation, informed consent, and institutional research procedures where appropriate.
-
Yes. Depending on the project, research may cover Singapore, Malaysia, Thailand, Indonesia, Vietnam, the Philippines, and other relevant Asian markets. Fieldwork scope is determined by the healthcare sector, target stakeholders, institutional access, and research objectives.
-
Most defined healthcare market research assignments require approximately 6–12 weeks, depending on research scope, stakeholder accessibility, and geographical coverage. Multi-country studies, institutional surveys, and detailed hospital feasibility assessments may require 10–16 weeks or longer.
-
Where required, specialised local research partners or healthcare professionals may support respondent recruitment, surveys, and country-specific data collection. Research design, analytical review, quality assurance, and recommendations remain subject to the agreed project management arrangements.
/ Contact Us
Let’s discuss how we can support your healthcare strategy across Asia.